Cargando…

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway

Janus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousoik, Emira, Montazeri Aliabadi, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079274/
https://www.ncbi.nlm.nih.gov/pubmed/30109213
http://dx.doi.org/10.3389/fonc.2018.00287
_version_ 1783345238639640576
author Bousoik, Emira
Montazeri Aliabadi, Hamidreza
author_facet Bousoik, Emira
Montazeri Aliabadi, Hamidreza
author_sort Bousoik, Emira
collection PubMed
description Janus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators of transcription (STATs), which in turn regulate the expression of a variety of proteins involved in induction or prevention of apoptosis. Therefore, the JAK/STAT signaling axis plays a major role in the proliferation and survival of different cancer cells, and may even be involved in resistance mechanisms against molecularly targeted drugs. Despite extensive research focused on the protein structure and mechanisms of activation of JAKs, and signal transduction through these proteins, their importance in cancer initiation and progression seem to be underestimated. This manuscript is an attempt to highlight the role of JAK proteins in cancer biology, the most recent developments in targeting JAKs, and the central role they play in intracellular cross-talks with other signaling cascades.
format Online
Article
Text
id pubmed-6079274
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60792742018-08-14 “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway Bousoik, Emira Montazeri Aliabadi, Hamidreza Front Oncol Oncology Janus tyrosine kinase (JAK) family of proteins have been identified as crucial proteins in signal transduction initiated by a wide range of membrane receptors. Among the proteins in this family JAK2 has been associated with important downstream proteins, including signal transducers and activators of transcription (STATs), which in turn regulate the expression of a variety of proteins involved in induction or prevention of apoptosis. Therefore, the JAK/STAT signaling axis plays a major role in the proliferation and survival of different cancer cells, and may even be involved in resistance mechanisms against molecularly targeted drugs. Despite extensive research focused on the protein structure and mechanisms of activation of JAKs, and signal transduction through these proteins, their importance in cancer initiation and progression seem to be underestimated. This manuscript is an attempt to highlight the role of JAK proteins in cancer biology, the most recent developments in targeting JAKs, and the central role they play in intracellular cross-talks with other signaling cascades. Frontiers Media S.A. 2018-07-31 /pmc/articles/PMC6079274/ /pubmed/30109213 http://dx.doi.org/10.3389/fonc.2018.00287 Text en Copyright © 2018 Bousoik and Montazeri Aliabadi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Bousoik, Emira
Montazeri Aliabadi, Hamidreza
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_full “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_fullStr “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_full_unstemmed “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_short “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
title_sort “do we know jack” about jak? a closer look at jak/stat signaling pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079274/
https://www.ncbi.nlm.nih.gov/pubmed/30109213
http://dx.doi.org/10.3389/fonc.2018.00287
work_keys_str_mv AT bousoikemira doweknowjackaboutjakacloserlookatjakstatsignalingpathway
AT montazerialiabadihamidreza doweknowjackaboutjakacloserlookatjakstatsignalingpathway